Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
6.52
-0.18 (-2.69%)
Mar 31, 2025, 12:27 PM EDT - Market open

Vir Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
8941,0111,3533,3695,4803,411
Upgrade
Market Cap Growth
-25.30%-25.30%-59.83%-38.52%60.63%147.35%
Upgrade
Enterprise Value
111209-2161,1544,6132,601
Upgrade
Last Close Price
6.707.3410.0625.3141.8726.78
Upgrade
PE Ratio
---6.5310.37-
Upgrade
Forward PE
----18.86-
Upgrade
PS Ratio
12.3013.6215.702.095.0044.67
Upgrade
PB Ratio
0.800.880.851.623.834.76
Upgrade
P/TBV Ratio
0.900.900.871.663.975.12
Upgrade
P/FCF Ratio
--2.11--
Upgrade
P/OCF Ratio
--2.03--
Upgrade
EV/Sales Ratio
1.502.82-0.714.2134.06
Upgrade
EV/EBITDA Ratio
--1.3710.81-
Upgrade
EV/EBIT Ratio
--1.3910.96-
Upgrade
EV/FCF Ratio
--0.72--
Upgrade
Debt / Equity Ratio
0.090.090.080.060.100.10
Upgrade
Debt / EBITDA Ratio
---0.150.31-
Upgrade
Debt / FCF Ratio
---0.08--
Upgrade
Asset Turnover
0.050.050.040.680.760.11
Upgrade
Quick Ratio
7.617.618.744.764.347.46
Upgrade
Current Ratio
8.718.719.064.934.587.80
Upgrade
Return on Equity (ROE)
-38.09%-38.09%-33.54%29.39%49.20%-52.36%
Upgrade
Return on Assets (ROA)
-19.72%-19.72%-17.50%21.89%18.31%-25.87%
Upgrade
Return on Capital (ROIC)
-22.08%-22.08%-21.08%27.58%22.32%-30.56%
Upgrade
Return on Capital Employed (ROCE)
---36.40%26.10%-
Upgrade
Earnings Yield
-56.81%-51.63%-45.45%15.31%9.65%-8.76%
Upgrade
FCF Yield
-49.37%-44.88%-59.14%47.35%-1.27%-5.79%
Upgrade
Buyback Yield / Dilution
-1.58%-1.58%0.50%-1.03%-11.98%-292.62%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q